Table of Content

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Pharmacogenomics Market
5. Voice of Customer
6. Global Pharmacogenomics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, Others)
6.2.2. By Service (Genotyping, SNP Identification, Pharmacogenetic Testing, Others)
6.2.3. By Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, Others)
6.2.4. By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. North America Pharmacogenomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Service
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. North America: Country Analysis
7.3.1. United States Pharmacogenomics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Service
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Canada Pharmacogenomics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Service
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. Mexico Pharmacogenomics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Service
7.3.3.2.3. By Application
7.3.3.2.4. By End User
8. Europe Pharmacogenomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Service
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Pharmacogenomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Service
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. Germany Pharmacogenomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Service
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. United Kingdom Pharmacogenomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Service
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Italy Pharmacogenomics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Service
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Spain Pharmacogenomics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Service
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. Asia Pacific Pharmacogenomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Service
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Pharmacogenomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Service
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. India Pharmacogenomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Service
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Japan Pharmacogenomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Service
9.3.3.2.3. By Application
9.3.3.2.4. By End User
9.3.4. South Korea Pharmacogenomics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Technology
9.3.4.2.2. By Service
9.3.4.2.3. By Application
9.3.4.2.4. By End User
9.3.5. Australia Pharmacogenomics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Technology
9.3.5.2.2. By Service
9.3.5.2.3. By Application
9.3.5.2.4. By End User
10. South America Pharmacogenomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Service
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Pharmacogenomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Service
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Argentina Pharmacogenomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Service
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. Colombia Pharmacogenomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Service
10.3.3.2.3. By Application
10.3.3.2.4. By End User
11. Middle East and Africa Pharmacogenomics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Technology
11.2.2. By Service
11.2.3. By Application
11.2.4. By End User
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Pharmacogenomics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Technology
11.3.1.2.2. By Service
11.3.1.2.3. By Application
11.3.1.2.4. By End User
11.3.2. Saudi Arabia Pharmacogenomics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Technology
11.3.2.2.2. By Service
11.3.2.2.3. By Application
11.3.2.2.4. By End User
11.3.3. UAE Pharmacogenomics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Technology
11.3.3.2.2. By Service
11.3.3.2.3. By Application
11.3.3.2.4. By End User
11.3.4. Egypt Pharmacogenomics Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Technology
11.3.4.2.2. By Service
11.3.4.2.3. By Application
11.3.4.2.4. By End User
11.3.5. Turkey Pharmacogenomics Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Technology
11.3.5.2.2. By Service
11.3.5.2.3. By Application
11.3.5.2.4. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Abbott Laboratories, Inc.
14.2. Illumina, Inc.
14.3. Thermo Fischer Scientific, Inc.
14.4. AstraZeneca Plc.
14.5. F.Hoffmann-La Roche AG
14.6. Bio-Rad Laboratories, Inc.
14.7. Becton, Dickinson and Company
14.8. Eurofins Scientific SE
14.9. Pacific Biosciences of California Inc.
14.10. Qiagen N.V.
14.11. PerkinElmer, Inc.
14.12. Oxford Nanopore Technologies Limited
14.13. Agilent Technologies, Inc.
14.14. Myriad Genetics, Inc
14.15. Admera Health, LLC
15. Strategic Recommendations